newsfilter
← Latest News
Business Wire·

MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today